Thursday, October 30, 2014

Bayer AG Third Quarter 2014 Results
and News Conference Call

Third quarter of 2014:

Bayer operationally strong – strategic focus on Life Science businesses

Sales advance in all subgroups – double-digit percentage growth for CropScience and the Pharmaceuticals Division (Fx & portfolio adj.) / Group sales EUR 10,187 million (plus 5.6 percent / Fx & portfolio adj.: plus 7.4 percent) / EBIT improves by 12.7 percent to EUR 1,376 million / EBITDA before special items increases by 1.4 percent to EUR 2,011 million / Net income advances by 12.7 percent to EUR 826 million / Core earnings per share grow by 6.3 percent to EUR 1.35 / Guidance for full year 2014 raised / Plan to float MaterialScience on the stock market » more

Links

Recording of the news conference call (dubbed into English):

Subscribe to our Bayer Group Events podcast via RSS or iTunes.


Last updated: October 30, 2014 Copyright © Bayer AG
http://www.bayer.com